News: BGF-backed MiP Diagnostics launches synthetic antibody solution for high sensitivity Covid-19 testing - Healthcare Newsdesk
BGF portfolio company, MIP Diagnostics Ltd. this week announced the launch of its COVID-19 nanoMIP for diagnostic sensors, a synthetic alternative to …
